Literature DB >> 14646684

Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride.

Takeshi Ishibashi1, Norihiko Yokoi, Shigeru Kinoshita.   

Abstract

PURPOSE: To compare the short-term effects of timolol maleate with and without preservative (0.005% benzalkonium chloride) on pre-corneal tear film stability and corneal epithelial barrier function. SUBJECTS AND METHODS: The study population consisted of 20 healthy volunteers. To obtain baseline values, 7 days before the experiment the non-invasive breakup time of the pre-corneal tear film was measured using a tear specular microscope; corneal fluorescein uptake was measured with a fluorophotometer. Unpreserved or preserved 0.5% timolol was applied to one eye; the contralateral eye was exposed to the other drug. At 30 minutes after instillation, the pre-study tests were repeated.
RESULTS: Preserved timolol did, while unpreserved timolol did not, significantly reduce the non-invasive breakup time from the baseline values (baseline and post-exposure values 11.4 and 6.8 seconds, respectively, P = 0.008 for preserved timolol, and 11.7 vs. 11.0 seconds, P = 0.55 for unpreserved timolol). Corneal fluorescein uptake, on the other hand, was significantly increased upon exposure to either preserved or unpreserved timolol (baseline and post-exposure values 37.5 and 82.0 ng/ml, P < 0.001 for preserved timolol, and 35.4 vs. 57.6 ng/ml, P < 0.001 for unpreserved timolol). Preserved timolol exerted the greater effect (P = 0.028).
CONCLUSIONS: Exposure to preserved timolol resulted in significant instability in the pre-corneal tear film. Moreover, it disrupted the corneal epithelial barrier function to a greater degree than unpreserved timolol. The elimination of preservatives may be desirable in efforts to protect the integrity of the corneal surface and its interaction with the tear film.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14646684     DOI: 10.1097/00061198-200312000-00008

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  41 in total

1.  [Effect of applanation tonometry on precision of biometry measurements].

Authors:  T M Rabsilber; S Bueltmann; M P Holzer; G U Auffarth
Journal:  Ophthalmologe       Date:  2011-01       Impact factor: 1.059

2.  Effects of long-term topical anti-glaucoma medications on meibomian glands.

Authors:  Reiko Arita; Kouzo Itoh; Shuji Maeda; Koshi Maeda; Ayumu Furuta; Atsuo Tomidokoro; Makoto Aihara; Shiro Amano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-18       Impact factor: 3.117

Review 3.  Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue.

Authors:  J Javier Servat; C Robert Bernardino
Journal:  Drugs Aging       Date:  2011-04-01       Impact factor: 3.923

4.  Comparison of a non-preserved 0.1% T-Gel eye gel (single dose unit) with a preserved 0.1% T-Gel eye gel (multidose) in ocular hypertension and glaucomatous patients.

Authors:  D L Easty; G Nemeth-Wasmer; J-P Vounatsos; B Girard; N Besnainou; P Pouliquen; L Delval; J-F Rouland
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

5.  Cytoprotective effect of lacritin on human corneal epithelial cells exposed to benzalkonium chloride in vitro.

Authors:  Mary M Feng; Julia Baryla; Hong Liu; Gordon W Laurie; Robert L McKown; Negin Ashki; Dinesh Bhayana; Cindy M L Hutnik
Journal:  Curr Eye Res       Date:  2014-01-08       Impact factor: 2.424

6.  Effects of timolol-related ophthalmic solutions on cultured human conjunctival cells.

Authors:  Kazuhide Kawase; Wenzhong Lin; Yumiko Aoyama; Tetsuya Yamamoto; Masamitsu Shimazawa; Hideaki Hara
Journal:  Jpn J Ophthalmol       Date:  2010-12-30       Impact factor: 2.447

7.  A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension.

Authors:  David A Godfrey; Lee S Peplinski; Jeanette A Stewart; William C Stewart
Journal:  Clin Ophthalmol       Date:  2009-06-02

8.  Incidence, severity and factors related to drug-induced keratoepitheliopathy with glaucoma medications.

Authors:  Takeo Fukuchi; Kimiko Wakai; Kieko Suda; Tomoko Nakatsue; Hideko Sawada; Hiroaki Hara; Jun Ueda; Takayuki Tanaka; Akiko Yamada; Haruki Abe
Journal:  Clin Ophthalmol       Date:  2010-04-26

9.  Toxicity of antiglaucoma drugs with and without benzalkonium chloride to cultured human corneal endothelial cells.

Authors:  Masahiko Ayaki; Atsuo Iwasawa; Yoichi Inoue
Journal:  Clin Ophthalmol       Date:  2010-10-21

10.  Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost.

Authors:  Gregory Katz; Clark L Springs; E Randy Craven; Michela Montecchi-Palmer
Journal:  Clin Ophthalmol       Date:  2010-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.